SecBot SecBot
DEFA14A ·Filed Apr 22, 2026

STRO

SUTRO BIOPHARMA, INC.
NEUTRAL
Impact 3/10
Horizonimmediate Processed6mo ago SEC0001193125-26-170441
Proxy solicitation materials
Actionable Insight • Neutral

This is a routine annual meeting with no material changes. Monitor for any unexpected shareholder proposals or voting outcomes, but no immediate trading implications.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$34.83
T+0 close · Apr 22, 2026 · via day close
Latest settled
−35.14%
T+60 · $22.59
Vs SPY
−40.16%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 23 $34.83entry
  2. T+1 · 7mo ago −4.31%α −5.09% · $33.33
  3. T+5 · 7mo ago +1.61%α +0.13% · $35.39
  4. T+20 · 6mo ago −10.62%α −15.26% · $31.13
  5. T+60 · 4mo ago −35.14%α −40.16% · $22.59
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Sutro Biopharma is holding its annual shareholder meeting to elect directors, ratify auditors, and approve executive compensation. This is a routine corporate governance filing with no material financial or strategic changes.

Key Financial Metrics

Vote
director election
Meeting
2026-06-05

Key Facts

  • Sutro Biopharma is holding its annual shareholder meeting on June 5, 2026
  • Shareholders will vote on the election of Class II directors (Jane Chung, Connie Matsui, James Panek)
  • Shareholders will vote to ratify Ernst & Young LLP as the independent auditor
  • Shareholders will vote on a non-binding advisory vote on executive compensation

Financial Impact

No material financial impact from this filing

none

Risk Factors

  • None identified from this filing

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001193125-26-170441
Document: 0001193125-26-170441-index-headers.html0001193125-26-170441
Document: 0001193125-26-170441-index.html0001193125-26-170441
Document: 0001193125-26-170441.txt0001193125-26-170441

Track record

8 reports on STRO

Performance horizon

2 of 4 bullish or bearish reports moved the stock their way by T+1. Best: +50.74% at T+20 after the Mar 23, 2026 report. 3 of 4 went positive at some point.

Filters
  1. Nov 12, 20264d ago Press Release Bearish 5/10 Entry $9.82 to $9.32 Now $9.32 +5.09% ▲ +5.09% +3.18% vs SPY
  2. Nov 9, 20267d ago SC 13G Neutral 3/10 Entry $10.61 to $10.17 Now $9.32 −12.16% ▼ −4.15% −3.78% vs SPY
  3. Aug 12, 202613w ago 8-K Bullish 7/10 No price data
  4. Aug 12, 202613w ago Press Release Mixed 6/10 Entry $21.30 to $21.31 Now $9.32 −56.24% ▲ +0.05% −0.65% vs SPY
  5. Apr 22, 202629w ago DEFA14A Neutral 3/10 Viewing Entry $34.83 to $33.33 Now $9.32 −73.24% ▼ −4.31% −5.09% vs SPY
  6. Apr 19, 202630w ago Press Release Bullish 7/10 Entry $34.58 to $34.35 Now $9.32 −73.05% ▼ −0.67% −0.01% vs SPY
  7. Mar 23, 202634w ago S-3 Bearish 6/10 Entry $23.57 to $23.50 Now $9.32 +60.46% ▲ +0.30% +0.86% vs SPY
  8. Mar 23, 202634w ago Press Release Bullish 7/10 Entry $23.57 to $23.50 Now $9.32 −60.46% ▼ −0.30% −0.86% vs SPY
Showing 8 of 8

US Market Status

Market Closed · Opens in 6h 36m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 22, 2026